Beam Therapeutics Shares float
What is the Shares float of Beam Therapeutics?
The Shares float of Beam Therapeutics Inc. is 54.087M 79.38%
What is the definition of Shares float?
Shares float is the portion of shares of a corporation that are in the hands of public investors as opposed to locked-in stock.
= annual shares outstanding - closely held shares
Shares float represents the portion of shares of a corporation that are in the hands of public investors as opposed to locked-in stock held by promoters, company officers, controlling-interest investors, or government. This number is sometimes seen as a better way of calculating market capitalization because it provides a more accurate reflection of what public investors consider the company to be worth. In this context, the float may refer to all the shares outstanding that can be publicly traded
The float is calculated by subtracting the locked-in shares from outstanding shares. Stocks with smaller floats tend to be more volatile than those with larger floats. In general, the large holdings of founding shareholders, corporate cross-holdings, and government holdings in partially privatized companies are excluded when calculating the size of a public float.
Shares float of companies in the Health Care sector on NASDAQ compared to Beam Therapeutics
What does Beam Therapeutics do?
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen receptor T cell for the treatment of relapsed/refractory T-cell acute lymphoblastic leukemia. It also develops therapies for alpha-1 antitrypsin deficiency and glycogen storage disorder 1a; and therapies for ocular and central nervous system disorders. The company has a strategic alliance with Boston Children's Hospital; a research and clinical collaboration agreement with Magenta Therapeutics, Inc.; and a research collaboration with the Institute of Molecular and Clinical Ophthalmology Basel. It also has a research collaboration with Apellis Pharmaceuticals, Inc. to apply base editing technology for discovering new treatments for complement-driven diseases. Beam Therapeutics Inc. was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.
Companies with shares float similar to Beam Therapeutics
- ASOS Plc has Shares float of 53.982M 54.01%
- ASOS Plc has Shares float of 53.982M 54.01%
- Sino Gas has Shares float of 54.000M 25.00%
- TAO Commodities has Shares float of 54.001M 172.05%
- India Steel Works has Shares float of 54.008M 13.57%
- Computer And Technologies has Shares float of 54.062M 21.67%
- Beam Therapeutics has Shares float of 54.087M 79.38%
- Whirlpool has Shares float of 54.090M 89.05%
- Whirlpool has Shares float of 54.090M 84.77%
- Majestic Wine Plc has Shares float of 54.092M 73.66%
- Cache Exploration has Shares float of 54.099M 104.77%
- Petrox Resources has Shares float of 54.111M 98.15%
- CannPal Animal Therapeutics has Shares float of 54.118M 58.11%